[1]
Wang, X. et al. 2021. A novel stool-based SDC2 DNA methylation test is more robust than FIT and plasma CEA in detecting colorectal neoplasia in China. American Journal of Translational Medicine. 5, 1 (Mar. 2021), 37–50.